ATE108331T1 - Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis. - Google Patents
Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis.Info
- Publication number
- ATE108331T1 ATE108331T1 AT89122317T AT89122317T ATE108331T1 AT E108331 T1 ATE108331 T1 AT E108331T1 AT 89122317 T AT89122317 T AT 89122317T AT 89122317 T AT89122317 T AT 89122317T AT E108331 T1 ATE108331 T1 AT E108331T1
- Authority
- AT
- Austria
- Prior art keywords
- psoriasis
- treatment
- tnf
- medication
- manufacture
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29049788A | 1988-12-27 | 1988-12-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE108331T1 true ATE108331T1 (de) | 1994-07-15 |
Family
ID=23116275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89122317T ATE108331T1 (de) | 1988-12-27 | 1989-12-04 | Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0377823B1 (enExample) |
| JP (1) | JPH02209812A (enExample) |
| AT (1) | ATE108331T1 (enExample) |
| AU (1) | AU633037B2 (enExample) |
| CA (1) | CA2003981C (enExample) |
| DE (1) | DE68916777T2 (enExample) |
| DK (1) | DK658889A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2659235A1 (fr) * | 1990-03-09 | 1991-09-13 | Asahi Chemical Ind | Application du facteur tumoral de necrose au traitement des troubles de demyelinisation, de l'uveite ou des troubles de l'hote qui a recu une greffe. |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US8715664B2 (en) | 2005-05-16 | 2014-05-06 | Abbvie Biotechnology Ltd. | Use of human TNFα antibodies for treatment of erosive polyarthritis |
| TWI439284B (zh) | 2004-04-09 | 2014-06-01 | Abbvie Biotechnology Ltd | 用於治療ＴＮＦα相關失調症之多重可變劑量療法 |
| US9605064B2 (en) | 2006-04-10 | 2017-03-28 | Abbvie Biotechnology Ltd | Methods and compositions for treatment of skin disorders |
| CN106729633A (zh) * | 2017-03-03 | 2017-05-31 | 上海唯科生物制药有限公司 | 一种肿瘤坏死因子直肠给药制剂及其制备方法 |
| US20240108746A1 (en) * | 2020-12-16 | 2024-04-04 | Molecular Partners Ag | Novel slow-release prodrugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
| AU2844889A (en) * | 1988-01-22 | 1989-07-27 | Collagen Corporation | Method for suppressing the growth of normal and cancer cells |
-
1989
- 1989-11-27 CA CA002003981A patent/CA2003981C/en not_active Expired - Lifetime
- 1989-12-04 AT AT89122317T patent/ATE108331T1/de not_active IP Right Cessation
- 1989-12-04 DE DE68916777T patent/DE68916777T2/de not_active Expired - Lifetime
- 1989-12-04 EP EP89122317A patent/EP0377823B1/en not_active Expired - Lifetime
- 1989-12-19 AU AU46853/89A patent/AU633037B2/en not_active Ceased
- 1989-12-22 DK DK658889A patent/DK658889A/da not_active Application Discontinuation
- 1989-12-27 JP JP1336408A patent/JPH02209812A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| EP0377823A3 (en) | 1991-09-11 |
| EP0377823B1 (en) | 1994-07-13 |
| DE68916777T2 (de) | 1995-03-16 |
| EP0377823A2 (en) | 1990-07-18 |
| AU633037B2 (en) | 1993-01-21 |
| CA2003981A1 (en) | 1990-06-27 |
| AU4685389A (en) | 1990-07-05 |
| JPH0565492B2 (enExample) | 1993-09-17 |
| CA2003981C (en) | 2000-06-13 |
| JPH02209812A (ja) | 1990-08-21 |
| DE68916777D1 (de) | 1994-08-18 |
| DK658889D0 (da) | 1989-12-22 |
| DK658889A (da) | 1990-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE103914T1 (de) | Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen. | |
| AU576365B2 (en) | Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas | |
| DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
| IS4226A (is) | Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum | |
| DE59000270D1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
| DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| ATE108331T1 (de) | Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis. | |
| ATE94764T1 (de) | Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung. | |
| BG50159A3 (bg) | Метод за получаване на производни на пиранобензоксадиазол | |
| DE69301750D1 (de) | Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| ATE143809T1 (de) | Placentaextrakt und verfahren zu seiner herstellung | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
| ATE118221T1 (de) | Verwendung von tumornekrosefaktor. | |
| HU9202229D0 (en) | Method for manufacturing new pharmaceutical preparatives containing 2-oxo-benzimidaazoline-1-carboxylic acid derivatives | |
| DE69516602D1 (de) | Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie | |
| ATE127118T1 (de) | 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia. | |
| ATE145133T1 (de) | Verwendung von thiol-5-(2-diethyl-aminoethyl)- ester-verbindungen zur herstellung eines arzneimittels zur behandlung der neuromuskuläre inkontinenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |